The Psychedelics Lobby: Tracking Federal Lobbying by Psychedelics Companies and Nonprofits
With just over one month to go until Americans head to the polls, we’re taking a look at federal lobbying on psychedelics-related matters.
Here, we collate data on formal lobbying activity among psychedelic drug developers and nonprofits, which have collectively funnelled over $1.5 million into such efforts in the last two years.
Psychedelic Drug Developers
First up, let’s look at the lobbying dollars expended by psychedelic drug developers.
Join Today
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and research.
- Regular Bulletins featuring news, analysis, and research
- Articles and deep dives across psychedelic drug development, policy, and research
- Exclusive interviews with researchers, executives, and policymakers
- Bespoke resources and tools including the Psychedelic Bill Tracker
- Quarterly video briefings and slide decks
Already a member?
Sign In